Shuttle Pharmaceuticals Holdings (SHPH) EPS (Basic) (2021 - 2026)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly EPS (Basic) came in at -$5.0 in Q1 2026, up 93.62% year-on-year from -$2.58 in Q1 2025, and up 70.61% quarter-over-quarter from -$17.02 in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) EPS (Basic) (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' EPS (Basic) history runs 6 years deep, the most recent figure standing at -$5.0 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 93.62% year-over-year to -$5.0 in Q1 2026; TTM through Mar 2026 was -$23.64, a 90.5% increase from a year earlier, with the FY2025 full-year figure at -$120.28, up 89.14% from the prior year.
- EPS (Basic) climbed to -$5.0 in Q1 2026 per SHPH's latest filing, from -$17.02 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$5.0 in Q1 2026 and bottomed at -$849.8 in Q4 2022.
- The 5-year median for EPS (Basic) is -$151.98 (2022), against an average of -$195.34.
- Across the five-year window, EPS (Basic) tumbled 715.26% in 2022 and surged 96.89% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$849.8 in 2022, then jumped by 74.12% to -$219.91 in 2023, then jumped by 32.42% to -$148.62 in 2024, then surged by 88.55% to -$17.02 in 2025, then soared by 70.61% to -$5.0 in 2026.
- Per Business Quant, the three latest SHPH EPS (Basic) figures stand at -$5.0 (Q1 2026), -$17.02 (Q4 2025), and -$10.59 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 0.32 |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 6.32 |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 1.97 |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 0.11 |
| 10 | Shuttle Pharmaceuticals Holdings | 1.42 Mn | 1.42 Mn | - | -5.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.00 |
| Dec 31, 2025 | -17.02 |
| Sep 30, 2025 | -10.59 |
| Jun 30, 2025 | -37.51 |
| Mar 31, 2025 | -78.40 |
| Dec 31, 2024 | -148.62 |
| Sep 30, 2024 | -340.68 |
| Jun 30, 2024 | -225.55 |
| Mar 31, 2024 | -224.58 |
| Dec 31, 2023 | -219.91 |
| Sep 30, 2023 | -227.74 |
| Jun 30, 2023 | -306.32 |
| Mar 31, 2023 | -143.02 |
| Dec 31, 2022 | -849.80 |
| Sep 30, 2022 | -200.29 |
| Jun 30, 2022 | -133.82 |
| Mar 31, 2022 | -151.98 |
| Dec 31, 2021 | -104.24 |
| Sep 30, 2021 | -52.24 |